Thermo Fisher Scientific
TMO • NYSE
Thermo Fisher Scientific is a medical - diagnostics & research company in the healthcare sector trading on NYSE, led by CEO Marc N. Casper, with a market cap of $191.96B.
CEOMarc N. Casper
Market Cap$191.96B
Medical - Diagnostics & Research
Healthcare
Employees122.0K
Websitethermofisher.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Thermo Fisher Scientific
Date
Wednesday, April 22, 2026 (in 2 months)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$5.30
Revenue Estimate
$10.9B
Earnings History
Past 12 earnings reports for Thermo Fisher Scientific
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Jan 29, 2026 | Q4 2025 | $6.57Est: $6.44 | +2.0% | $12.2BEst: $11.9B | +2.5% | — |
| Oct 22, 2025 | Q3 2025 | $5.79Est: $5.50 | +5.3% | $11.1BEst: $10.9B | +1.9% |  10-Q |
| Jul 23, 2025 | Q2 2025 | $5.36Est: $5.23 | +2.5% | $10.9BEst: $10.7B | +1.7% | 10-Q |
| Apr 23, 2025 | Q1 2025 | $5.15Est: $5.10 | +1.0% | $10.4BEst: $10.2B | +1.3% | 10-Q |
| Jan 30, 2025 | Q4 2024 | $6.10Est: $5.94 | +2.7% | $11.4BEst: $11.3B | +1.0% | 10-K |
| Oct 23, 2024 | Q3 2024 | $5.28Est: $5.24 | +0.8% | $10.6BEst: $10.6B | -0.4% | 10-Q |
| Jul 24, 2024 | Q2 2024 | $5.37Est: $5.12 | +4.9% | $10.5BEst: $10.5B | +0.3% | 10-Q |
| Apr 24, 2024 | Q1 2024 | $5.11Est: $4.71 | +8.5% | $10.3BEst: $10.2B | +1.7% | 10-Q |
| Jan 31, 2024 | Q4 2023 | $5.67Est: $5.64 | +0.5% | $10.9BEst: $10.7B | +1.5% | 10-K |
| Oct 25, 2023 | Q3 2023 | $5.69Est: $5.61 | +1.4% | $10.6BEst: $10.6B | -0.2% | — |
| Jul 26, 2023 | Q2 2023 | $5.15Est: $5.42 | -5.0% | $10.7BEst: $11.0B | -2.7% | 10-Q |
| Apr 26, 2023 | Q1 2023 | $5.03Est: $5.03 | 0.0% | $10.7BEst: $10.7B | +0.4% | 10-Q |